Company joins five other MPP patent holders in efforts to improve HIV paediatric care [Reposted from the Medicines Patent Pool, Link, (CC-BY-NC-ND)] The Medicines Patent Pool (MPP) announced a licence today with MSD, known as Merck in the United States and Canada, for paediatric formulations of raltegravir, a key medicine approved for children living with [...]
↧